Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

DPD courier 4.99 € GLS courier 9.99 €

Contact

How to shop

Help

My account

▸ Empty :-(

Combating Autism Act

Name: Combating Autism Act
Brand: Nova Science Publishers Inc
SKU: 06440502
Price: 205.19 EUR
Availability: InStock
Author: Deryck Harlow
ISBN: 9781633211285

Elements, Funding & Analyses

Deryck Harlow

Language

English

Book Hardback

Libristo code: 06440502

Publishers Nova Science Publishers Inc, August 2014

Autism spectrum disorder (ASD) and autism are general terms for a group of developmental disabilitie... Full description

Libristo code: 06440502

498 b

205.19 €

50 % chance We search the world When will I receive my book?

Up to 30 days for returns

Customers also purchased

Mark Knopfler (Volumen 1, Dire Straits) - el apasionante libro de 530 páginas, edición especial en espa?ol Richard Koechli

Paperback

19.97 €

Unfreiheit der Friesen zwischen Weser und Jade Robert Allmers

Paperback

24.10 €

SWOT-Analyse als Instrument zur Produktimplementierung im Gesundheitstourismus Gerhard Gstettner

Paperback

42.66 €

Die Zusage im öffentlichen Recht. Nikolaus Pfander

Paperback

63.85 €

Die Spur der Füchse Ken Follett

Paperback

11.79 €

Autism spectrum disorder (ASD) and autism are general terms for a group of developmental disabilities that cause impairments in social skills and communication, and are often characterised by certain atypical behaviours. The federal government has a role in the financing (through Medicaid and State Children''s Health Insurance Programs) and delivery of treatment for ASD. The number of autism cases and their appropriate diagnosis and treatment affect federal and state expenditures. As such, Congress has shown interest in financing research on ASD prevalence, causes, and optimal treatment for individuals with ASD. This book presents an overview of the Combating Autism Act and Combating Autism Reauthorization Act, the Department of Health and Human Services funding, other federal activities related to autism, and selected issues for Congress. It also describes the actions that HHS agencies have taken as a result of the CAA; examines the oversight of CAA grantees; analyses the extent to which federal agencies fund potentially duplicative autism research; and assesses the extent to which IACC and agencies co-ordinate and monitor federal autism activities.